drug

CRD-4730

1 story · latest Aug 6, 2026

Status: Investigational
Trials: 1 registered trial in coverage

Relationships

Developed by Cardurion Pharmaceuticals, Inc

Timeline

Cardurion registers Phase 2 CALIBRATE-HF trial of CaMKII inhibitor CRD-4730 in HFrEF

Aug 6Trial updateCardurion Pharmaceuticals, Inc CRD-4730

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.